-
Merck & Cie et al v. Watson Laboratories Inc. DC CAFC
- 1:13-cv-01272
- D. Del.
- Judge: Richard G. Andrews
- Filed: 07/23/2013
- Closed: 08/18/2016
- Latest Docket Entry: 11/14/2017
- PACER
3
Plaintiffs
2
Defendants
1
Accused
Product
1
Patent-in-Suit
1,123
Days in
Litigation
-
Merck & Cie et al v. Watson Laboratories Inc. DC CAFC
- 1:13-cv-01272
- D. Del.
- Judge: Richard G. Andrews
- Filed: 07/23/2013
- Closed: 08/18/2016
- Latest Docket Entry: 11/14/2017
- PACER
Market Sector
Biotech and Pharma
Court
Assigned Judge
Outcome Summary
- Patent Information
-
Validity & Enforceability
| Claim # | Claim Text | Outcome |
|---|---|---|
| 4 |
A crystalline calcium salt of 5-methyl-(6S)-tetrahydrofolic acid with 2 theta values of 6.5, 13.3, 16.8 and 20.1 (Type I) said crystalline salt having a water of crystallization of at least one equivalent per equivalent of 5-methyltetrahydrofolic
view more
|
Valid (102 and 103 and 112)
Entry 130 Entry 114 |
-
Infringement
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Generic version of Beyaz tablets | US 6,441,168 B1 |
4
|
No infringement
Entry 130
|
